Osteolytic Skull Metastasis with Dural Involvement from a Papillary Thyroid Carcinoma by Karlo Houra et al.
Coll. Antropol. 35 (2011) 3: 919–922
Case report
Osteolytic Skull Metastasis with Dural
Involvement from a Papillary Thyroid Carcinoma
Karlo Houra1, Majda Vu~i}2, Hrvoje ^upi}2, Damir Kova~3 and Vatroslav ^erina3
1 »Sv. Katarina« Hospital, Zabok, Croatia
2 University of Zagreb, »Sestre milosrdnice« University Hospital Center, »Ljudevit Jurak« University Department of Pathology,
Zagreb, Croatia
3 University of Zagreb, »Sestre milosrdnice« University Hospital Center, Department of Neurosurgery, Zagreb, Croatia
A B S T R A C T
Skull metastatic tumors are relatively rare medical entities and originate most often from the lungs, breast or pros-
tate.We report a case of a 76-year-old woman who presented with a bulging, well-circumscribed mass on the right side of
the forehead. Neuroimaging of the cranium detected an osteolytic lesion measuring 7 cm in the largest diameter while
propagating outwards and intracranially. A thorough medical history revealed that patient had undergone surgery for
invasive breast ductal carcinoma and also for a well-differentiated thyroid carcinoma 13 years ago. Considering patients
medical history metastatic breast carcinoma was suspected. After a frontal craniotomy the tumour tissue was totally
resected. Histological examination revealed metastatic papillary carcinoma characterized by ground-glass nuclei with
intranuclear pseudo inclusion and nuclear grooves. We report clinical and neuroradiological features of this uncommon
lesion and discussed the differential diagnosis of skull osteolytic lesion together with the treatment management.
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Introduction
Metastatic tumours to the skull are relatively rare
and originate most often from the lung, breast or pro-
state1. Most metastatic skull lesions are asymptomatic.
Skull and dural metastases from a well-differentiated
thyroid carcinoma are very uncommon2–5. Papillary thy-
roid carcinoma usually remains intrathyroidal and tends
to metastasize only to the regional lymph nodes6. We de-
scribe a case of skull metastasis with a dural involve-
ment from a papillary thyroid carcinoma 13 years after
thyroidectomy and discuss the differential diagnosis of
skull osteolytic lesion together with the treatment man-
agement.
Case Report
A 76-year-old female was admitted at our Department
of Neurosurgery due to the growing tender mass on the
right side of her forehead. The patient complained on
headache and confusion together with sleeping distur-
bance. A thorough medical history revealed that she had
undergone the right-sided mastectomy and a lympha-
denectomy due to the invasive ductal carcinoma in the
stage T2N0M0 13 years ago. She had also undergone a
surgery for a well-differentiated thyroid carcinoma when
left total lobectomy and partial right lobectomy was per-
formed. The diagnosis was papillary thyroid carcinoma
stage T2 without extension beyond the thyroid gland.
Ever since she is under a continuous surgical control in-
cluding regularly chest X-rays and abdominal ultrasound
that revealed no metastatic disease. Endocrinological
control including thyroid function tests was within nor-
mal limits. Repeated fine needle cytological aspiration of
the residual thyroid gland was negative for malignant
cells. Regional cervical lymph nodes were also clear with
no signs of local recurrence.
In the last year the patient noticed a gradually grow-
ing, soft and well-circumscribed mass with no neurologi-
cal deficits what so ever. A local examination revealed a
palpatory, subcutaneous, non-pulsating, soft, right frontal
egzophytic swelling. Haematological, biochemical tests
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and chest X-ray did not reveal any abnormal findings.
The patient’s neurological examination did not disclose
any abnormal findings. A plain X-ray showed an elliptical
area lucency of 8 cm in diameter in the right frontal
bone. A computed tomography (CT) scan revealed an ir-
regular bone defect measuring 7 cm in largest diameter
involving both the inner and the outer table of the skull
in the right frontal region together with multilobulated
egzophytic lesion that was propagating mostly outwards
but also intracranially compressing the adjacent dura
and brain (Figure 1). Considering patients medical his-
tory a metastatic brain carcinoma was suspected. After a
complete neuroradiological evaluation, the patient un-
derwent surgery.
A semicircular incision of the skin was made and the
galea was differentiated from the coetaneous flap. It was
infiltrated by the brown multilobulated, soft, vascular
tumour tissue (Figure 2). The tumour tissue was then
resected at the bone level after which we have performed
a right-sided frontal craniotomy, encompassing the bone
defect. After elevating the eroded bone flap, it was clear
that the tumour had started to infiltrate the dura. No in-
filtration under the dura was evident upon its opening.
At the end a cranioplasty with Palacos was performed.
Postoperative recovery was uneventful.
Histological hematoxylin-eozin (H&E) slides revealed
a tumour lesion composed of a follicular growth pattern
containing colloid and oedematous papillary structures
with the fibrovascular core covered by the epithelium
with characteristic nuclear features that include enlar-
ged, oval shaped and overlapping nuclei with typically
ground glass appearance (Figure 3). The tumour had in-
filtrated between the bone trabecula with focally dural
infiltration. Additional immunostaining with anti-thyro-
globulin antibody stained most tumour cells. Based on
these findings, a definitive diagnosis of a metastasis from
the papillary carcinoma of the thyroid was made.
A total body radioiodine (I-131) scan didn’t detect ac-
tivity. A follow-up cranial CT scan showed no tumour re-
currence. Ten months later patient’s general condition
remained well.
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Fig. 1. Cranial CT scan; transversal (A), coronal sections (B) and bone window (C) irregular bone defect involving both the inner and
outer table of the skull in the right frontal region.
Fig. 2. Surgically removed specimen; the brown multilobulated,
softly tumour tissue mass.
Fig. 3. Metastatic lesion between bone trabecula composed of
follicular growth pattern containing colloid and lined by epithe-
lium with characteristic nuclear features with typically ground
glass appearance (H&E x200).
Discussion
Skull metastases are found at 5–6% of patients with
advanced systemic cancer. Clinically they cause local
swelling that is usually painless and rarely lead to neuro-
logical dysfunction1. Dural involvement developed in 15%
of these cases by direct extension from skull metastasis,
usually produces neurological deficit and sometimes sub-
dural haematomas4,7,8. Metastatic lesions of the skull are
result of haematogenous seeding with tumour emboli
that occurs initially in the red marrow5. Skull metastases
spread most often from the lungs, breast, prostate or a
renal cell carcinoma. Breast cancer is associated with the
highest rate of the metastatic skull lesion1,9. Bone meta-
stases may be osteolytic, sclerotic or mixed on radio-
graphs. Osteolytic metastases are encountered most fre-
quently, especially in the breast and a lung carcinoma.
Papillary carcinoma of the thyroid generally carries a
good prognosis. It usually remains intrathyroidal and
tends to metastasise locally to regional lymph nodes2.
Distant spread may occur to the lungs or bones but ex-
ceptionally to the skull. Bone metastases are usually de-
veloped after the appearance of lung metastases. Typi-
cally multiple lesions are present within the 10 years
after surgery10. Incidence of bone metastases from a well-
-differentiated thyroid papillary carcinoma was 0.4–1%,
and from follicular thyroid carcinoma was 6–8%2,8,11. The
most common site for bone metastases from well-differ-
entiated thyroid carcinoma is the spine. The most fre-
quent histopathological presentation in the case of skull
metastases was also follicular thyroid carcinoma12. There
are several reports of skull metastasis from thyroid pap-
illary carcinoma3,5-7,13,14. Even when they spread, which
is extremely rare, they usually metastasize in the brain
parenchyma and not in the skull15. Such a cranial meta-
static lesion can become threatening in a more aggres-
sive manner, particularly in the older patients. The pre-
ferred treatment algorithm for most primary thyroid
carcinomas is near-total thyroidectomy followed by post-
operative 131-I ablation and in the absence of 131-I up-
take, external beam radiation therapy is preferred15. Pa-
tients should also be on chronic TSH suppression to
control disease progression.
Cranial osteolytic metastatic lesions can clinically and
radiologically mimic osteocartilaginous skull tumours or
tumour-like lesions. The diffential diagnosis includes a
chondroma that radiographically appears as a lytic lesion
mostly at the base of the skull with fairly sharp margins.
CT reveals well marginated bone destruction and an as-
sociated homogenous, isodense and lobulated soft tissue
mass with interspersed calcification. Chondrosarcomas
develop usually in adults, as a malignant transformation
in a benign chondroma. They grow for a long period of
time and produce the pain and a deformity. CT reveals an
irregular destructive process with a homogenous, hy-
perdense, and enhancing soft tissue mass10. In a case of
solitary plasmocytomas and multiple myeloma skull x-
-rays show solitary lytic lesion or multiple punched areas
of bone destruction16. Other rare tumours, such as, retic-
ulum cell sarcoma, angiosarcoma, malignant fibrous hi-
stiocytoma can also be presented as an osteolytic bone
lesions17. Osteomyelitic changes appear radiologically long
after the onset of clinical signs and symptoms. Multiple
nodular lucent areas appear in the outer table or in the
diploe. Later they condense into large defects with scalp
oedema (Pott’s puffy tumour)10,16. As radiological find-
ings are not specific, biopsy with pathohistology may be
needed to confirm the diagnosis of such osteolytic le-
sions.
Conclusion
Solitary metastasis of differentiated thyroid cancer to
the skull is extremely rare. It is of no surprise then, that
the differential diagnosis for skull tumours does not cus-
tomarily include these lesions, but a strong argument
can be made that it should, regardless of the patient's age
and especially in patients with previous history of thy-
roid carcinoma. In our case report a solitary, lytic skull
lesion, considering the patients medical history and a
statistical probability, was suspected to be a metastasis of
a breast cancer. This was not the case however. The pa-
tient presented with a skull metastasis of a well-differen-
tiated thyroid papillary carcinoma that was totally surgi-
cally removed 13 years ago without local progression or
lung involvement. The metastases of thyroid tumours
are most frequent from the follicular carcinomas, while
papillary carcinoma tends to metastasize in the regional
nodes or in the lung. Bone metastasis is usually seen af-
ter the appearance of lung metastasis within the first 10
years after surgery.
If possible, a histologic tissue diagnosis should always
be attempted, followed by total thyroidectomy, 131-I, or
external beam radiation and chronic TSH suppression.
Surgical resection of the metastasis is recommended as a
curative option for increasing patient survival and also to
maximize the effect of subsequent radioiodine treatment
therapy. Patients with dural infiltration and related neu-
rologic deficit should be treated surgically to relieve
symptoms and therefore improve the quality of life.
Moreover in the case of solitary metastasis without addi-
tional metastases radical extirpation of bone metastasis
was associated with improved survival.
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OSTEOLITI^KA METASTAZA LUBANJE PAPILARNOG KARCINOMA [TITNJA^E S DURALNOM
PROPAGACIJOM
S A @ E T A K
Metastatski tumori lubanje relativno su rijetki medicinski entiteti te se naj~e{}e javljaju kod karcinoma plu}a, dojke
i prostate. U ovome smo radu prezentirali slu~aj sedamdeset{estogodi{nje bolesnice koja je u na{u kliniku do{la s jasno
ograni~enim izbo~enjem na desnoj strani ~ela. Neuroradiolo{kim slikanjem glave na{li smo osteoliti~ku leziju veli~ine 7
cm u naj{irem promjeru koja se propagirala intrakranijalno ali i ekstrakranijalno. Uzimanjem temeljite anamneze saz-
nali smo da je bolesnica pred dvanaest godina operirala invazivni duktalni karcinom dojke kao i dobro diferencirani
karcinom {titnja~e. Uzimaju}i u obzir anamnezu postavili smo sumnju na metastazu karcinoma dojke. Nakon frontalne
kraniotomije tumor smo u potpunosti odstranili. Patohistolo{kom je analizom ustvr|eno da se radi o metastazi papilar-
nog karcinoma {titnja~e ~ije stanice karakteriziraju svijetle jezgre s intranuklearnim pseudoinkluzijama te pregrada-
ma. U radu smo stoga prikazali cjelovitu klini~ku prezentaciju bolesti, neuroradiolo{ke karakteristike ovog netipi~nog
procesa, obradili smo diferencijalne dijagnoze drugih osteoliti~kih lezija lubanje te mogu}e na~ine lije~enja.
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